1. Home
  2. PCRX vs MNTK Comparison

PCRX vs MNTK Comparison

Compare PCRX & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.15

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Montauk Renewables Inc.

MNTK

Montauk Renewables Inc.

HOLD

Current Price

$1.89

Market Cap

231.9M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
MNTK
Founded
2006
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
231.9M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
PCRX
MNTK
Price
$26.15
$1.89
Analyst Decision
Strong Buy
Hold
Analyst Count
7
3
Target Price
$32.86
$3.33
AVG Volume (30 Days)
916.7K
166.4K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$716,791,000.00
$160,682,000.00
Revenue This Year
$6.24
$2.45
Revenue Next Year
$9.53
$15.31
P/E Ratio
$55.91
N/A
Revenue Growth
3.14
N/A
52 Week Low
$18.17
$1.56
52 Week High
$27.64
$4.96

Technical Indicators

Market Signals
Indicator
PCRX
MNTK
Relative Strength Index (RSI) 60.78 51.97
Support Level $25.48 $1.78
Resistance Level $27.16 $1.98
Average True Range (ATR) 1.02 0.11
MACD 0.10 0.02
Stochastic Oscillator 66.84 65.79

Price Performance

Historical Comparison
PCRX
MNTK

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About MNTK Montauk Renewables Inc.

Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.

Share on Social Networks: